Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2019-07-09 (6 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: AIX-EN-PROVENCE (13100), Bouches-du-Rhone
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELURL PHARMACIE LE BEL ORMEAU : revenue, balance sheet and financial ratios
SELURL PHARMACIE LE BEL ORMEAU is a French company
founded 6 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in AIX-EN-PROVENCE (13100),
this company of category PME
shows in 2025 a net income positive of 96 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELURL PHARMACIE LE BEL ORMEAU (SIREN 852274703)
Indicator
2025
2024
2023
2022
2021
2020
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
Net income
96 429 €
89 427 €
72 531 €
27 381 €
103 447 €
-137 234 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, SELURL PHARMACIE LE BEL ORMEAU generates positive net income of 96 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
96 429 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 372%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 17%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
372.295%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
17.429%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SELURL PHARMACIE LE BEL ORMEAU
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2020
2021
2022
2023
2024
2025
Debt ratio
-5319.302
2806.831
1834.917
962.821
565.375
372.295
Financial autonomy
-1.685
3.0
4.4
7.868
12.413
17.429
Repayment capacity
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
372.32025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Average
In 2025, the debt ratio of SELURL PHARMACIE LE BEL O... (372.30) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
17.43%2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Watch
In 2025, the financial autonomy of SELURL PHARMACIE LE BEL O... (17.4%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 67.75. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
67.75
Liquidity indicators evolution SELURL PHARMACIE LE BEL ORMEAU
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2020
2021
2022
2023
2024
2025
Liquidity ratio
115.384
113.986
83.591
83.185
61.188
67.75
Interest coverage
None
None
None
None
None
None
Sector positioning
Liquidity ratio
67.752025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Watch
In 2025, the liquidity ratio of SELURL PHARMACIE LE BEL O... (67.75) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Positioning of SELURL PHARMACIE LE BEL ORMEAU in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of SELURL PHARMACIE LE BEL ORMEAU is estimated at
1 531 786 €
(range 1 039 477€ - 2 403 583€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
1039k€1531k€2403k€
1 531 786 €Range: 1 039 477€ - 2 403 583€
NAF 5 année 2025
Valuation method used
Net Income Multiple
96 429 €
×
15.9x
=1 531 786 €
Range: 1 039 477€ - 2 403 583€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELURL PHARMACIE LE BEL ORMEAU with other companies in the same sector:
Frequently asked questions about SELURL PHARMACIE LE BEL ORMEAU
What is the revenue of SELURL PHARMACIE LE BEL ORMEAU ?
The revenue of SELURL PHARMACIE LE BEL ORMEAU is not publicly disclosed (confidential accounts filed with INPI).
Is SELURL PHARMACIE LE BEL ORMEAU profitable?
Yes, SELURL PHARMACIE LE BEL ORMEAU generated a net profit of 96 k€ in 2025.
Where is the headquarters of SELURL PHARMACIE LE BEL ORMEAU ?
The headquarters of SELURL PHARMACIE LE BEL ORMEAU is located in AIX-EN-PROVENCE (13100), in the department Bouches-du-Rhone.
Where to find the tax return of SELURL PHARMACIE LE BEL ORMEAU ?
The tax return of SELURL PHARMACIE LE BEL ORMEAU is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELURL PHARMACIE LE BEL ORMEAU operate?
SELURL PHARMACIE LE BEL ORMEAU operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart